NEW YORK (GenomeWeb) – Constance, Germany-based sequencing services firm GATC Biotech announced on Dec. 2 a structural reorganization that divides its products and services into three divisions.

Sequencing Solutions will house the firm's Sanger sequencing and next-generation sequencing services, including its NGSelect and InView products. Customized Solutions will oversee consulting and project design services. Diagnostic Solutions will target opportunities to apply the firm's sequencing capabilities in areas such as oncology and companion diagnostics.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.